Belgium - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Belgium Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 7.2% year on year. In 2019, the country was ranked number 229 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 17 Cases. India topped the ranking with 66,255 Cases in 2019, that is a growth of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 17.00 |
2018 | 9.00 |
2017 | 8.00 |
2016 | 12.00 |
2015 | 17.00 |
Download all data from 2005 to 2019
How does Belgium rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
229 |
#229
Austria
|
17 | 2019 | +0.0 % | -19.4 % | View data | |
229 |
#229
Belgium
|
17 | 2019 | +88.9 % | +7.2 % | View data | |
229 |
#229
Sweden
|
17 | 2019 | +6.3 % | -1.1 % | View data |